Abstract
Mutations in the cardiac ryanodine receptor (RYR2) are the leading cause for catecholaminergic polymorphic ventricular tachycardia (CPVT). In this study, we evaluated antiarrhythmic efficacy of carvedilol and flecainide in CPVT patient-specific induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) carrying different mutations in RYR2. iPSC-CMs were generated from skin biopsies of CPVT patients carrying exon 3 deletion and L4115 or V4653F mutation in RYR2 and of a healthy individual. Ca2+ kinetics and drug effects were studied with Fluo-4 AM indicator. Carvedilol abolished Ca2+ abnormalities in 31% of L4115F, 36% of V4653F, and 46% of exon 3 deletion carrying CPVT cardiomyocytes and flecainide 33%, 30%, and 52%, respectively. Both drugs lowered the intracellular Ca2+ level and beating rate of the cardiomyocytes significantly. Moreover, flecainide caused abnormal Ca2+ transients in 61% of controls compared to 26% of those with carvedilol. Carvedilol and flecainide were equally effective in CPVT iPSC-CMs. However, flecainide induced arrhythmias in 61% of control cells. CPVT cardiomyocytes carrying the exon 3 deletion had the most severe Ca2+ abnormalities, but they had the best response to drug therapies. According to th...Continue Reading
References
Mar 21, 1991·The New England Journal of Medicine·D S EchtH L Greene
Jul 11, 2003·Lancet·Philip A Poole-WilsonUNKNOWN Carvedilol Or Metoprolol European Trial Investigators
Aug 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Dawei JiangS R Wayne Chen
Feb 17, 2009·BMC Medical Genetics·Annukka MarjamaaHeikki Swan
Mar 31, 2009·Nature Medicine·Hiroshi WatanabeBjörn C Knollmann
Jun 19, 2009·Current Protocols in Stem Cell Biology·Mari OhnukiShinya Yamanaka
Oct 20, 2009·Journal of Molecular and Cellular Cardiology·Fredrick A HilliardBjörn C Knollmann
May 28, 2011·Journal of the American College of Cardiology·Christian van der WerfArthur A M Wilde
Jun 8, 2011·Structure·Paolo A LoboFilip Van Petegem
Jun 18, 2011·Circulation Research·Nian LiuSilvia G Priori
Jul 12, 2011·Nature Medicine·Qiang ZhouS R Wayne Chen
Mar 1, 2012·Circulation Research·Yijun TangS R Wayne Chen
Jul 4, 2012·Journal of the American College of Cardiology·Ilanit ItzhakiLior Gepstein
Sep 11, 2012·PloS One·Kirsi KujalaKatriina Aalto-Setälä
Feb 5, 2015·Circulation Research·Mark L BannisterAlan J Williams
Apr 11, 2015·Circulation Research·Godfrey L Smith, Niall MacQuaide
May 9, 2015·PloS One·Kirsi PenttinenKatriina Aalto-Setälä
Jul 15, 2015·Journal of Molecular and Cellular Cardiology·Dario MelgariJules C Hancox
Sep 9, 2015·The Biochemical Journal·Jingqun ZhangS R Wayne Chen
Aug 5, 2016·Disease Models & Mechanisms·Marcela K PreiningerChunhui Xu
Oct 7, 2016·Science·Wei PengNieng Yan
Nov 20, 2016·Current Opinion in Cardiology·Thomas M RostonShubhayan Sanatani
Jun 21, 2017·Circulation. Arrhythmia and Electrophysiology·Leonid MaizelsLior Gepstein
Citations
Oct 5, 2019·Nature Reviews. Cardiology·Joost A OfferhausArthur A M Wilde
May 13, 2020·Cells·Disheet ShahKatriina Aalto-Setälä
Oct 11, 2019·Cardiovascular Research·Marta LemmeThomas Eschenhagen
Jun 6, 2019·Materials·Mari Pekkanen-MattilaKatriina Aalto-Setälä
Feb 6, 2020·Molecular Pharmacology·Amir AshnaDerek Laver
Sep 10, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Vladena Bauerová-HlinkováJacob A Bauer
Dec 2, 2019·Molecular Biology Reports·R P PölönenK Aalto-Setälä
Jul 5, 2018·Biology Open·Chandra PrajapatiKatriina Aalto-Setälä
Sep 16, 2020·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Xiao-Hua ZhangMartin Morad
Dec 17, 2020·Journal of Cardiovascular Pharmacology·Michelangelo PaciJussi T Koivumäki
Mar 23, 2021·Frontiers in Cardiovascular Medicine·Laura Iop
May 8, 2021·World Journal of Stem Cells·Miruna Mihaela Micheu, Ana-Maria Rosca